Icon

Safyral - (3mg,N/A; 0.03mg,N/A; 0.451mg,0.451mg, Tablet, Oral)

Drospirenone and Ethinyl Estradiol and Levomefolate Calcium and Levomefolate Calcium Bayer
3mg,N/A; 0.03mg,N/A; 0.451mg,0.451mg, Tablet, Oral
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
None
Less Than 5
Less Than 5
Indicated in women who choose to use an oral contraceptive as their method of contraception, to raise folate levels for the purpose of reducing the risk of a neural tube defect in a pregnancy conceived while taking the product or shortly after discontinuing the product.
Yes
****** ** *** ***** ** **** **** ** **** ******* **** ****** '*** (***** **, ****) *** *** ************ *********. ******** ***** ***** *** ****** ** ***** *** ********* ** ******. ****** ***** ***** **** ** **** **** ****** *** *** ************ *********. ****** ******** *** ******** ** ******* ******* ***** ******* ******* ******** *** ******** *****'* ******* ******* **** *** ****** '*** ** *******. ******* ***** ***** ** ****** ** ******* ***** ***** ******* ***** **** ******** ******* *******'* ********, ** ********* *** ****** ** *******. ***** *** ***** ***** ******* ********** *** **** ******** ***** '*** *** **** *** *** **** ** *** **********.
Safyral Patent 1 Patent 2 Patent 3 Patent 4
****** *** ********* *** ********* *** ********* *** ** **
***** *** ********* *** ********* *** ********* *** ** **
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ ** *** *, **** *** ** ** ******** *** ****** *** ****
***** ** \ ** *** **, **** *** ** ** ******** ******** ** *** *, ****
  1. *** **, **** : ****** ******** ***** ***** *** **** ** *** ******* **** ******* '*** (***** **, ****).
  2. *** **, **** : ***** ***** **** ******* ****** ** ******** ***** ** ******.
  3. *** **, **** : ***** ***** * **** ******* ***** ** ***** ***** **** ** **** ****** '*** (***** **, ****).
  4. *** *, **** : ********** *** ****** **** ***** **** *** ******* ** ******* ******* ** *** ****** ****.
  5. *** **, **** : ***** ***** ******* ****** ******* **** ****** '*** ** ***** *** ********* ** ******.
  6. *** **, **** : ****** ******** *** ******** ** ******* *******.
  7. *** **, **** : ******* ******* ******** ******** ***** ****** ******* **** '*** ****** ** *******.
  8. *** **, **** : ***** ******** *** ******** ** ******* *****.
  9. *** **, **** : * ********* ** ******* ** ***** ** ***** ****, '*** ****** ** *** ********* ** *****
  10. *** *, **** : ******* ***** ******** ******* *******'* ******** ** ********* *** ****** ** *******.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.